Comprehensive Rimonabant Evaluation Study of Cardiovascular Endpoints and Outcomes - CRESCENDO

Description:

The goal of the trial was to evaluate treatment with the endocannabinoid receptor rimonabant compared with placebo in patients with overt vascular disease or increased risk for vascular disease.